Trivalent inactivated influenza vaccine (IIV3) during pregnancy and six-month infant development

OBJECTIVE: Despite recommendations by professional organizations that all pregnant women receive inactivated influenza vaccine, safety concerns remain a barrier. Our objective was to assess the effect of trivalent influenza vaccines (IIV3) during pregnancy on parent report 6-month infant development...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Vaccine
Autori principali: Avalos, Lyndsay A., Ferber, Jeannette, Zerbo, Ousseny, Naleway, Allison L., Bulkley, Joanna, Thompson, Mark, Cragan, Janet, Williams, Jennifer, Odouli, Roxana, Kauffman, Tia L., Ball, Sarah, Shifflett, Pat, Li, De-Kun
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7309563/
https://ncbi.nlm.nih.gov/pubmed/32033850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2020.01.059
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi